Project Grant HT94252510990
Award Date 11/1/25
Completion Date 10/31/27
Dollars Obligated $233K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
- The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,759,708.00 to Iowa State University of Science and Technology to conduct research on high-throughput, high-resolution in vitro models of prostate cancer bone marrow metastases. The research project runs from April 15, 2025 to April 14, 2028 and aims to develop innovative medical solutions that address critical health challenges relevant to military...
- This $1,399,501 federal Project Grant awarded by the Defense Health Agency on September 1, 2023 will fund the development of a novel DNA aptamer-based IFN-γ targeted therapy for chronic cystitis pain at the University of Iowa. The project, which is scheduled for completion by August 31, 2027, aligns with the objectives of the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to transform healthcare for Service Members and the American public through...
- The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
- The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The University of Iowa was awarded a $399,990.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420), administered by the Defense Health Agency. The grant will support a 2-year research project titled "Spatial Proteogenomics to Identify Novel Prognostic and Predictive Biomarkers in Melanoma", with an award period from November 1, 2025 to October 31, 2027. The objective of this research is to leverage advanced spatial proteogenomics techniques to...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- This federal Project Grant award, totaling $3,560,880, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The primary awardee, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct sophisticated scientific investigations to address various medical...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,618,500.00 to the Regents of the University of Minnesota to conduct research titled "TARGETING EIF4F COMPLEX-DRIVEN TRANSLATION OF ONCOGENIC MRNAS IN CRPC". The 3-year award, starting on June 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
- This $1,844,306 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Michigan to cotarget the NSD1/2 paralogs in androgen receptor (AR)-driven castration-resistant prostate cancer. The research aims to transform healthcare for military service members, veterans, and the public by developing innovative medical solutions to address critical health challenges. The project will run...